It has been indicated in many studies that the metabolic pathway of CSCs should be aerobic glycolysis, which could be initiated by pyruvate dehydrogenase kinase1 (PDK1) to enhance stemness in mouse model; glycolysis was also found to contribute to breast cancer stem cells (BCSCs) and as a potential therapeutic strategy for breast cancer [18]. The gene discussed is PDK1; the disease is breast cancer.